 |
PDBsum entry 1nn6
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.21.39
- chymase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Phe-|-Xaa > Tyr-|-Xaa > Trp-|-Xaa > Leu-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
42:2616-2624
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
|
|
K.K.Reiling,
J.Krucinski,
L.J.Miercke,
W.W.Raymond,
G.H.Caughey,
R.M.Stroud.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Human chymase is a protease involved in physiological processes ranging from
inflammation to hypertension. As are all proteases of the trypsin fold, chymase
is synthesized as an inactive "zymogen" with an N-terminal pro region that
prevents the transition of the zymogen to an activated conformation. The 1.8 A
structure of pro-chymase, reported here, is the first zymogen with a dipeptide
pro region (glycine-glutamate) to be characterized at atomic resolution. Three
segments of the pro-chymase structure differ from that of the activated enzyme:
the N-terminus (Gly14-Gly19), the autolysis loop (Gly142-Thr154), and the 180s
loop (Pro185A-Asp194). The four N-terminal residues (Gly14-Glu15-Ile16-Ile17)
are disordered. The autolysis loop occupies a position up to 10 A closer to the
active site than is seen in the activated enzyme, thereby forming a hydrogen
bond with the catalytic residue Ser195 and occluding the S1' binding pocket.
Nevertheless, the catalytic triad (Asp102-His57-Ser195) is arrayed in a geometry
close to that seen in activated chymase (all atom rmsd of 0.52 A). The 180s loop
of pro-chymase is, on average, 4 A removed from its conformation in the
activated enzyme. This conformation disconnects the oxyanion hole (the amides of
Gly193 and Ser195) from the active site and positions only approximately 35% of
the S1-S3 binding pockets in the active conformation. The backbone of residue
Asp194 is rotated 180 degrees when compared to its conformation in the activated
enzyme, allowing a hydrogen bond between the main-chain amide of residue Trp141
and the carboxylate of Asp194. The side chains of residues Phe191 and Lys192 of
pro-chymase fill the Ile16 binding pocket and the base of the S1 binding pocket,
respectively. The zymogen positioning of both the 180s and autolysis loops are
synergistic structural elements that appear to prevent premature proteolysis by
chymase and, quite possibly, by other dipeptide zymogens.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.A.Stoop,
R.V.Joshi,
C.T.Eggers,
and
C.S.Craik
(2010).
Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activation.
|
| |
Biol Chem,
391,
425-433.
|
 |
|
|
|
|
 |
A.D.Vogt,
A.Bah,
and
E.Di Cera
(2010).
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.
|
| |
J Phys Chem B,
114,
16125-16130.
|
 |
|
|
|
|
 |
Z.Chen,
L.A.Pelc,
and
E.Di Cera
(2010).
Crystal structure of prethrombin-1.
|
| |
Proc Natl Acad Sci U S A,
107,
19278-19283.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Bah,
C.J.Carrell,
Z.Chen,
P.S.Gandhi,
and
E.Di Cera
(2009).
Stabilization of the E* form turns thrombin into an anticoagulant.
|
| |
J Biol Chem,
284,
20034-20040.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Di Cera
(2009).
Serine proteases.
|
| |
IUBMB Life,
61,
510-515.
|
 |
|
|
|
|
 |
R.Sharma,
V.Prasad,
E.T.McCarthy,
V.J.Savin,
K.N.Dileepan,
D.J.Stechschulte,
E.Lianos,
T.Wiegmann,
and
M.Sharma
(2007).
Chymase increases glomerular albumin permeability via protease-activated receptor-2.
|
| |
Mol Cell Biochem,
297,
161-169.
|
 |
|
|
|
|
 |
C.Bacani,
and
W.H.Frishman
(2006).
Chymase: a new pharmacologic target in cardiovascular disease.
|
| |
Cardiol Rev,
14,
187-193.
|
 |
|
|
|
|
 |
G.H.Caughey
(2006).
A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.
|
| |
Curr Respir Med Rev,
2,
263-277.
|
 |
|
|
|
|
 |
W.W.Raymond,
S.W.Ruggles,
C.S.Craik,
and
G.H.Caughey
(2003).
Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site.
|
| |
J Biol Chem,
278,
34517-34524.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |